Pillstats
Rx only · Tablet · Oral

Ticagrelor

Brands: Brilinta · Ticagrelor

17 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US30 NDCs
17 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers17 labelers
Packages53
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.04$2.07$3.11$4.14Dec 2025Apr 2026Jul 2026
$1.310
Latest avg · Jul 22, 2026
-64%
Since Dec 17, 2025
17
Active US suppliers
26%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

30K61K91K122K2025 Q12025 Q22025 Q32025 Q42026 Q1
64K
Rx · 2026 Q1
4.9M
Units dispensed
-39%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it17 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novadoz Pharmaceuticals LLCunknown8SUPPLYING
Dr.Reddy's laboratories Limitedunknown6SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown6SUPPLYING
Bionpharma Inc.unknown4SUPPLYING
Changzhou Pharmaceutical Factoryunknown4SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown3SUPPLYING
AstraZeneca Pharmaceuticals LPunknown3SUPPLYING
AiPing Pharmaceutical, Inc.unknown3SUPPLYING
RADHA PHARMACEUTICALS, INC.unknown2SUPPLYING
Cardinal Health 107, LLCunknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING
Ascend Laboratories, LLCunknown2SUPPLYING
American Health Packagingunknown2SUPPLYING
Oryza Pharmaceuticals Inc.unknown2SUPPLYING
AvKAREunknown2SUPPLYING

+ 2 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 15, 2021
    RECALLRecall (Class II): Brilinta ticagrelar tablets 60 mg 60 tablets Rx only NDC 0186-0776-60 Mfd. for: AstraZeneca LP, Wilmington, DE 19850

    CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC

  • May 25, 2017
    RECALLRecall (Class I): BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd. for: AstraZeneca Pharmaceutica…

    Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets. — Recalling firm: AstraZeneca Pharmaceuticals, LP — Nationwide in the USA and Puerto Rico to physician offices.